Back to User profile » Dr Jie Chen
Papers published by Dr Jie Chen:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Combination Of ALBI And APRI To Predict Post-Hepatectomy Liver Failure After Liver Resection For HBV-Related HCC Patients
Mai R, Wang Y, Bai T, Chen J, Xiang B, Wu G, Wu F, Li L, Ye J
Cancer Management and Research 2019, 11:8799-8806
Published Date: 2 October 2019
Prognostic value of preoperative computed tomography in HBV-related hepatocellular carcinoma patients after curative resection
Zhang W, Chen J, Liu L, Wang L, Liu J, Su D
OncoTargets and Therapy 2019, 12:3791-3804
Published Date: 16 May 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma
Mai RY, Ye JZ, Long ZR, Shi XM, Bai T, Chen J, Li LQ, Wu GB, Wu FX
Cancer Management and Research 2019, 11:1401-1414
Published Date: 12 February 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
Wu F, Lu H, Zhu S, Li Z, Zou L, Bai T, Chen J, Yang T, Liang S
OncoTargets and Therapy 2016, 9:7141-7147
Published Date: 1 December 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis
Luo T, Chen J, Liu JJ, Li H, You XM, Wang HL, Zhu SL, Li LQ
OncoTargets and Therapy 2016, 9:4483-4489
Published Date: 21 July 2016